Screener
Oruka Therapeutics, Inc. ORKA Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055769
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Series B non-voting convertible preferred stock, $0.001 par value; 251,504 shares authorized as of March 31, 2026 and December 31, 2025; 137,138 shares issued and outstanding as of March 31, 2026 and December 31, 2025 | 2,931 | 2,931 |
| Common stock, $0.001 par value; 545,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 50,167,623 and 48,722,309 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 50 | 49 |
| Additional paid-in capital | 705,196 | 657,561 |
| Accumulated other comprehensive income (loss) | (480) | 546 |
| Accumulated deficit | (220,977) | (189,157) |
| Total stockholders’ equity | 486,720 | 471,930 |
| Total liabilities and stockholders’ equity | $504,480 | $488,617 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Oruka Therapeutics, Inc.'s total equity?
- Oruka Therapeutics, Inc. (ORKA) reported total equity of $486.72M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s total equity changed year-over-year?
- Oruka Therapeutics, Inc.'s total equity increased by 33.4% year-over-year, from $364.73M to $486.72M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s total equity has grown at a 58.9% compound annual growth rate (CAGR), from $46.52M to $471.93M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Oruka Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude